Bone morphology in response to alendronate as seen by high-resolution computed tomography: Through a glass darkly

Journal of Bone and Mineral Research

Volumn 25, Issue 12, 2010, Pages 2553-2557

  Seeman, Ego ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; PLACEBO; RALOXIFENE;

AGING; BONE DENSITOMETRY; BONE DENSITY; BONE GROWTH; BONE REMODELING; COMPUTER ASSISTED TOMOGRAPHY; DRUG ACTIVITY; DRUG MECHANISM; DRUG RESPONSE; FINITE ELEMENT ANALYSIS; HUMAN; MINERALIZATION; NONHUMAN; NOTE; POSTMENOPAUSE; STEADY STATE;

EID: 78649561022     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.261     Document Type: Note

References (31)

1. Seeman E, Delmas PD., Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med. 2006; 354: 2250-2261.
2. Parfitt AM., Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis. In:, Marcus R, Feldman D, Nelson DA, Rosen CJ, eds. Osteoporosis. San Diego, CA: Academic Press, 71-89. 2008.
3. Laib A, Hauselmann HJ, Ruegsegger P., In vivo high resolution 3D-QCT of the human forearm. Technol Health Care. 1998; 6: 329-337.
4. MacNeil JA, Boyd SK., Accuracy of high-resolution peripheral quantitative computed tomography for measurement of bone quality. Med Eng Phys. 2007; 29: 1096-1105.
5. Vico L, Zouch M, Amirouche A, et al. High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures. J Bone Miner Res. 2008; 23: 1741-1750.
6. Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD., Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res. 2007; 22: 425-433.
7. Burghardt AJ, Kazakia GJ, Sode M, De Papp AE, Link TM, Majumdare S., A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: relations between density, cortical and trabeculare microarchitecture, biomechanics, and bone turnover. J Bone Miner Res. 2010.
8. Allen MR, Follet H, Khurana M, Sato M, Burr DB., Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib. Calcif Tissue Int. 2006; 79: 255-261.
9. Parfitt A., Morphological basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Miner Electrolyte Metab. 1980; 4: 273-287.
10. Allen MR, Erickson AW, Wang X, Burr DB, Martin RB, Hazelwood SJ., Morphological assessment of basic multicellular unit resorption parameters in dogs shows additional mechanisms of bisphosphonate effects on bone. Calcif Tissue Int. 2010; 86: 67-71.
11. Boivin G, Meunier PJ., Changes in bone remodeling rate influence the degree of mineralization of bone. Connect Tissue Res. 2002; 43: 535-537.
12. Parfitt AM., The physiologic and clinical significance of bone histomorphometric data. In:, Recker R, ed. Bone Histomorphometry: Techniques and Interpretations. Boca Raton, FL: CRC Press, 142-223. 1983.
13. Bone HG, Hosking D, Devogelaer J-P, et al. Ten years experience with alendronate for osteoporosis in postmenopausal women. New Eng J Med. 2004; 350: 1189-1199.
14. McClung MR, Lewiecki EM, Cohen SB, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006; 354: 821-831.
15. Saag K, Lindsay R, Kriegman A, Beamer E, Zhou W., A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density. Bone. 2007; 40: 1238-1243.
16. Reid IR, Mason B, Horne A, et al. Randomized, controlled trial of calcium in healthy older women. Am J Med. 2006; 119: 777-785.
17. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women treated with raloxifene. JAMA. 1999; 282: 637-645.
18. Mashiba T, Hirano T, Turner CH, et al. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2000; 2000; 15: 613-620.
19. Tang SY, Allen MR, Phipps R, Burr DB, Vashishth D., Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int. 2009; 20: 887-894.
20. Meunier PJ, Sellami S, Briancon D, Edouard C., Histological heterogeneity of apparently idiopathic osteoporosis. In:, Deluca HF, Frost HM, Jee WSS, et al., eds. Osteoporosis: Recent Advances in Pathogenesis and Treatment. Baltimore: Williams & Wilkins, 293-301. 1990.
21. Johnston CC, Nortin J, Khairi MRA, et al. Heterogeneity of fracture syndromes in postmenopausal women. J Clin Endocrinol Metab. 1985; 61: 551-556.
22. Ciarelli TE, Fyhrie DP, Parfitt AM., Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone. 2003; 32: 311-315.
23. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL., Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res. 1990; 5: 311-319.
24. Zebaze R, Ghasem-Zadeh A, Bohte A, et al. Intracortical remodeling and porosity: rational targets for fracture prevention. Lancet. 2010; 375: 1729-1736.
25. Seeman E., Growth in bone mass and size are racial and gender differences in bone mineral density are more apparent than real ? J Clin Endocrinol Metab. 1998; 83: 1414-1419.
26. MacNeil JA, Boyd SK., Improved reproducibility of high-resolution peripheral quantitative computed tomography for measurement of bone quality. Med Eng Phys. 2008; 30: 792-799.
27. Boyd SK., Site-specific variation of bone micro-architecture in the distal radius and tibia. J Clin Densitom. 2008; 11: 424-430.
28. Sekhon K, Kazakia GJ, Burghardt AJ, Hermannsson B, Majumdar S., Accuracy of volumetric bone mineral density measurement in high-resolution peripheral quantitative computed tomography. Bone. 2009; 45: 473-479.
29. Davis KA, Burghardt AJ, Link TM, Majumdar S., The effects of geometric and threshold definitions on cortical bone metrics assessed by in vivo high-resolution peripheral quantitative computed tomography. Calcif Tissue Int. 2007; 81: 364-371.
30. Borah B, Dufresne T, Nurre J, et al. Risedronate reduces intracortical porosity in women with osteoporosis. J Bone Miner Res. 2010; 25: 41-47.
31. Zebaze R, Seeman E, Ghasem-Zadeh A, et al., Analysis System and Method. Australian Provisional Patent No. 2009904407.